Patient Outcomes Transcatheter Aortic Valve Replacement

Excellent Safety Profile

Survival

Low Pacemaker Rates

Disabling Stroke

Low PVL Rates


Low PVL Rates1

Evolut™ PRO 30-day outcomes

EvolutPRO 30day PVL

Unsurpassed Hemodynamics1

Evolut PRO valve performance

1

Forrest, et al., ACC, 2017
Evolut PRO Clinical Study, 60 patients, 30-day outcomes.